- Home
- VTGN vs LRFC Comparison
VTGN vs LRFC Comparison
Compare VTGN & LRFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTGN
- LRFC
- Stock Information
- Founded
- VTGN 1998
- LRFC 2013
- Country
- VTGN United States
- LRFC United States
- Employees
- VTGN N/A
- LRFC N/A
- Industry
- VTGN Biotechnology: Pharmaceutical Preparations
- LRFC Finance: Consumer Services
- Sector
- VTGN Health Care
- LRFC Finance
- Exchange
- VTGN Nasdaq
- LRFC Nasdaq
- Market Cap
- VTGN 82.7M
- LRFC 66.5M
- IPO Year
- VTGN N/A
- LRFC 2013
- Fundamental
- Price
- VTGN $2.93
- LRFC $24.78
- Analyst Decision
- VTGN
- LRFC
- Analyst Count
- VTGN 0
- LRFC 0
- Target Price
- VTGN N/A
- LRFC N/A
- AVG Volume (30 Days)
- VTGN 192.7K
- LRFC 9.8K
- Earning Date
- VTGN 02-13-2025
- LRFC 03-13-2025
- Dividend Yield
- VTGN N/A
- LRFC 5.41%
- EPS Growth
- VTGN N/A
- LRFC N/A
- EPS
- VTGN N/A
- LRFC N/A
- Revenue
- VTGN $698,000.00
- LRFC $19,936,000.00
- Revenue This Year
- VTGN N/A
- LRFC $3.63
- Revenue Next Year
- VTGN N/A
- LRFC N/A
- P/E Ratio
- VTGN N/A
- LRFC N/A
- Revenue Growth
- VTGN N/A
- LRFC N/A
- 52 Week Low
- VTGN $2.22
- LRFC $20.65
- 52 Week High
- VTGN $5.74
- LRFC $26.00
- Technical
- Relative Strength Index (RSI)
- VTGN 53.66
- LRFC 52.18
- Support Level
- VTGN $2.72
- LRFC $24.22
- Resistance Level
- VTGN $3.10
- LRFC $25.00
- Average True Range (ATR)
- VTGN 0.19
- LRFC 0.34
- MACD
- VTGN 0.00
- LRFC 0.01
- Stochastic Oscillator
- VTGN 66.00
- LRFC 71.79
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
About LRFC Logan Ridge Finance Corporation
Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.